Mechanisms of neuronal network dysfunction in juvenile neuronal ceroid lipofuscinosis
幼年神经元蜡质脂褐质沉积症神经元网络功能障碍的机制
基本信息
- 批准号:10004182
- 负责人:
- 金额:$ 18.8万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2018
- 资助国家:美国
- 起止时间:2018-09-30 至 2023-08-31
- 项目状态:已结题
- 来源:
- 关键词:3-DimensionalAddressAdolescentAffectAfferent PathwaysAgeAutomobile DrivingAutopsyAwardBasic ScienceBiochemicalBiochemistryBlindnessBrainCLN3 proteinCellsCessation of lifeChildChildhoodClinicalConfocal MicroscopyDataDefectDementiaDevelopmentDiseaseDisorder of neurometabolic regulationDoctor of PhilosophyElectroencephalogramElectrophysiology (science)Excitatory SynapseFunctional disorderFundingFutureGene therapy trialGenesGoalsHippocampus (Brain)HumanImageImaging TechniquesImmunohistochemistryIncidenceIndividualInvestigationLeadLearningLinkLongevityLysosomal Storage DiseasesMeasurementMeasuresMediatingMentorsMetabolicMetabolic DiseasesModelingMorphologyMusMutationNerve DegenerationNervous System PhysiologyNeuraxisNeurocognitiveNeurologicNeurologic SymptomsNeuronal Ceroid-LipofuscinosisNeuronsNeurosciencesOutcomePaperPathologyPatientsPerforant PathwayPhenotypePhysiciansPhysiologyPopulationPropertyPublicationsScientistSecondary toSeizuresSliceSpielmeyer-Vogt DiseaseStructureSymptomsSynapsesTestingTherapeuticTimeLineTrainingTranslatingVariantWorkbasecareerdentate gyrusdrug discoveryenzyme replacement therapyexperiencegranule cellimaging studyimprovedimproved functioninginsightmouse modelnetwork dysfunctionneural circuitneurobiotinneuronal circuitryneuropathologynew therapeutic targetnovelnovel strategiesnovel therapeuticspatch clamppostnatalprotein expressionreconstructionresponserestorationskillssymptomatic improvementsynaptic functiontherapy developmenttranslational scientistvoltage sensitive dye
项目摘要
PROJECT SUMMARY
Most metabolic diseases, including two-thirds of lysosomal storage disorders (LSD) affect the brain. For many,
including Juvenile Neuronal Ceroid Lipofuscinosis (JNCL), it is not known how the biochemical defect induces
central nervous system dysfunction. Studies have focused on cellular-level pathology, with few investigations
of how metabolic defects disrupt functional neuronal circuits. Ultimately, disruption of brain networks leads to
the symptoms, such as seizures and neurocognitive regression, that are devastating to patients.
JNCL results from biallelic mutations in CLN3. How loss of CLN3 protein disrupts neurologic function is
unclear. In preliminary work, I have demonstrated that JNCL mice, like human patients, have abnormal
electroencephalograms, suggesting mice are a suitable model for circuit-level studies. On autopsy, JNCL
brains show neurodegeneration and lysosomal storage accumulation; the hippocampus is especially
vulnerable. In my preliminary voltage-sensitive dye imaging (VSDI) studies of the JNCL mouse hippocampus, I
have found progressive changes in excitability. Also, recent studies of late-stage JNCL show synaptic
dysfunction in the mouse hippocampus. However, in studies of late-stage disease it is impossible to parse
which changes are due to the primary loss of CLN3 protein or secondary to widespread neuropathology.
Gene and/or enzyme replacement therapy is being developed for many LSDs. While this is exciting, moving to
gene-based treatment before we know if replacement will fix the patients is problematic. Where and when to
rescue protein expression is unclear. A major unanswered question is if correction of the biochemical defect
underlying a metabolic disease will rescue the function of neuronal networks and improve symptoms.
My central hypothesis is that in JNCL, hippocampal circuit pathology arises from synaptic dysfunction induced
by loss of CLN3 protein. Because of the development of abnormal network dynamics, a vulnerable window
may exist beyond which correction of single cell biochemistry will not correct functional defects. I will evaluate
this by: 1) defining circuit level pathology using VSDI in two JNCL models; 2) exploring the synaptic and
cellular changes driving network changes, and 3) assessing if rescue of CLN3 expression at different stages of
disease can rescue circuit and synaptic dynamics. This work has important implications for future studies of the
basic science of the CLN3 protein and novel therapies for JNCL.
As an MD/PhD, I am passionate about translating basic science discoveries into new therapies for my patients
with neurometabolic disorders. My mentors Dr. Eric Marsh, a physician-scientist neurogeneticist and
electrophysiologist, and Dr. Beverly Davidson, a lysosomal storage disease expert, have devoted their careers
to this goal. Under their guidance, I will use this 5-year experience to learn to apply my electrophysiology skills
to studies of the brain and to prepare for a career as an independent R01-funded translational researcher.
项目概要
大多数代谢疾病,包括三分之二的溶酶体贮积症 (LSD) 都会影响大脑。对于许多人来说,
包括幼年神经元蜡质脂褐质沉着症(JNCL),目前尚不清楚生化缺陷如何诱发
中枢神经系统功能障碍。研究主要集中在细胞水平的病理学上,很少有调查
代谢缺陷如何破坏功能性神经元回路。最终,大脑网络的破坏导致
癫痫发作和神经认知衰退等症状对患者来说是毁灭性的。
JNCL 是 CLN3 双等位基因突变的结果。 CLN3 蛋白的缺失如何破坏神经功能
不清楚。在前期工作中,我已经证明 JNCL 小鼠与人类患者一样,具有异常
脑电图,表明小鼠是电路级研究的合适模型。尸检时,JNCL
大脑出现神经变性和溶酶体储存积累;海马体尤其
易受伤害的。在我对 JNCL 小鼠海马体的初步电压敏感染料成像 (VSDI) 研究中,我
发现兴奋性逐渐变化。此外,最近对晚期 JNCL 的研究表明突触
小鼠海马体功能障碍。然而,在晚期疾病的研究中,不可能解析
这些变化是由于 CLN3 蛋白的原发性丢失或继发于广泛的神经病理学所致。
正在为许多 LSD 开发基因和/或酶替代疗法。虽然这令人兴奋,但转向
在我们知道替代疗法是否能治愈患者之前进行基于基因的治疗是有问题的。何时何地
救援蛋白的表达尚不清楚。一个尚未解答的主要问题是是否可以纠正生化缺陷
潜在的代谢疾病将挽救神经元网络的功能并改善症状。
我的中心假设是,在 JNCL 中,海马回路病理是由突触功能障碍引起的
CLN3 蛋白的丢失。由于网络动态的异常发展,易受攻击的窗口
可能存在超出该范围的单细胞生物化学校正将无法纠正功能缺陷。我会评价
这是通过以下方式实现的:1) 在两个 JNCL 模型中使用 VSDI 定义电路级病理学; 2)探索突触和
细胞变化驱动网络变化,3) 评估是否在不同阶段挽救 CLN3 表达
疾病可以挽救神经回路和突触动力学。这项工作对未来的研究具有重要意义
CLN3 蛋白的基础科学和 JNCL 的新疗法。
作为一名医学博士/博士,我热衷于将基础科学发现转化为患者的新疗法
患有神经代谢紊乱。我的导师埃里克·马什 (Eric Marsh) 博士是一位医师科学家神经遗传学家
电生理学家和溶酶体贮积病专家 Beverly Davidson 博士将他们的职业生涯奉献给了
为了这个目标。在他们的指导下,我将利用这5年的经验来学习应用我的电生理学技能
进行大脑研究,并为成为 R01 资助的独立转化研究员的职业生涯做好准备。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Rebecca Clare Ahrens-Nicklas其他文献
Rebecca Clare Ahrens-Nicklas的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Rebecca Clare Ahrens-Nicklas', 18)}}的其他基金
Network modulation to improve gene therapy in CLN3 disease
网络调节改善 CLN3 疾病的基因治疗
- 批准号:
10579621 - 财政年份:2023
- 资助金额:
$ 18.8万 - 项目类别:
Disease Severity Stratification in Multiple Sulfatase Deficiency
多种硫酸酯酶缺乏症的疾病严重程度分层
- 批准号:
10700164 - 财政年份:2022
- 资助金额:
$ 18.8万 - 项目类别:
Disease Severity Stratification in Multiple Sulfatase Deficiency
多种硫酸酯酶缺乏症的疾病严重程度分层
- 批准号:
10513906 - 财政年份:2022
- 资助金额:
$ 18.8万 - 项目类别:
Network modulation to improve gene therapy in CLN3 disease
网络调节改善 CLN3 疾病的基因治疗
- 批准号:
10626675 - 财政年份:2022
- 资助金额:
$ 18.8万 - 项目类别:
The 2021 Multiple Sulfatase Deficiency Scientific and Family Meeting
2021 年多种硫酸酯酶缺乏症科学和家庭会议
- 批准号:
10318766 - 财政年份:2021
- 资助金额:
$ 18.8万 - 项目类别:
Mechanisms of neuronal network dysfunction in juvenile neuronal ceroid lipofuscinosis
幼年神经元蜡质脂褐质沉积症神经元网络功能障碍的机制
- 批准号:
9789984 - 财政年份:2018
- 资助金额:
$ 18.8万 - 项目类别:
Mechanisms of neuronal network dysfunction in juvenile neuronal ceroid lipofuscinosis
幼年神经元蜡质脂褐质沉积症神经元网络功能障碍的机制
- 批准号:
10457437 - 财政年份:2018
- 资助金额:
$ 18.8万 - 项目类别:
Mechanisms of neuronal network dysfunction in juvenile neuronal ceroid lipofuscinosis
幼年神经元蜡质脂褐质沉积症神经元网络功能障碍的机制
- 批准号:
10248394 - 财政年份:2018
- 资助金额:
$ 18.8万 - 项目类别:
Investigation of arrhythmias in anthropomorphized murine cardiac myocytes.
拟人化小鼠心肌细胞心律失常的研究。
- 批准号:
7544841 - 财政年份:2008
- 资助金额:
$ 18.8万 - 项目类别:
Investigation of arrhythmias in anthropomorphized murine cardiac myocytes.
拟人化小鼠心肌细胞心律失常的研究。
- 批准号:
7690884 - 财政年份:2008
- 资助金额:
$ 18.8万 - 项目类别:
相似海外基金
Enhancing Structural Competency in School-Based Health Centers to Address LGBTQ+ Adolescent Health Equity
增强校本健康中心的结构能力,以解决 LGBTQ 青少年健康公平问题
- 批准号:
10608426 - 财政年份:2023
- 资助金额:
$ 18.8万 - 项目类别:
Application and feasability of a brief digital screening tool to address parental and adolescent tobacco and electronic cigarette use in pediatric medical care - a pilot study
简短的数字筛查工具的应用和可行性,以解决儿科医疗中父母和青少年烟草和电子烟的使用问题 - 一项试点研究
- 批准号:
486580 - 财政年份:2022
- 资助金额:
$ 18.8万 - 项目类别:
Studentship Programs
Co-design of an intervention to address alcohol use among adolescent boys and young men in Tanzania
共同设计一项干预措施,解决坦桑尼亚青春期男孩和年轻男性的饮酒问题
- 批准号:
MR/V032380/1 - 财政年份:2022
- 资助金额:
$ 18.8万 - 项目类别:
Research Grant
Complex intervention to optimise adolescent BMI pre-conception to address the double burden of malnutrition: A RCT in rural and urban South Africa
优化青少年孕前体重指数以解决营养不良的双重负担的复杂干预措施:南非农村和城市的随机对照试验
- 批准号:
MR/V005790/1 - 财政年份:2021
- 资助金额:
$ 18.8万 - 项目类别:
Research Grant
Application of a brief digital screening tool to address parental and adolescent tobacco and electronic cigarette use in pediatric medical care
应用简短的数字筛查工具来解决儿科医疗中父母和青少年烟草和电子烟的使用问题
- 批准号:
455984 - 财政年份:2021
- 资助金额:
$ 18.8万 - 项目类别:
Operating Grants
Complex intervention to optimise adolescent BMI pre-conception to address the double burden of malnutrition: A RCT in rural and urban South Africa
优化青少年孕前体重指数以解决营养不良的双重负担的复杂干预措施:南非农村和城市的随机对照试验
- 批准号:
MR/V005790/2 - 财政年份:2021
- 资助金额:
$ 18.8万 - 项目类别:
Research Grant
Development of the Cannabis Actions and Practices (CAP): A Parent-Focused Intervention to Address Adolescent Marijuana Use
大麻行动和实践 (CAP) 的发展:以家长为中心的干预措施,解决青少年大麻使用问题
- 批准号:
10057761 - 财政年份:2020
- 资助金额:
$ 18.8万 - 项目类别:
Development of the Cannabis Actions and Practices (CAP): A Parent-Focused Intervention to Address Adolescent Marijuana Use
大麻行动和实践 (CAP) 的发展:以家长为中心的干预措施,解决青少年大麻使用问题
- 批准号:
10213683 - 财政年份:2020
- 资助金额:
$ 18.8万 - 项目类别:
Targeted interventions to address the multi-level effects of gender-based violence on PrEP uptake and adherence among adolescent girls and young women in Kenya
有针对性的干预措施,以解决性别暴力对肯尼亚少女和年轻妇女接受和坚持 PrEP 的多层面影响
- 批准号:
9403567 - 财政年份:2017
- 资助金额:
$ 18.8万 - 项目类别:
Designing targeted interventions to address HIV vulnerabilities and improve clinical outcomes among conflict affected adolescent girls and young women under 25 in Northern Uganda
设计有针对性的干预措施,以解决乌干达北部受冲突影响的少女和 25 岁以下年轻妇女的艾滋病毒脆弱性并改善临床结果
- 批准号:
356145 - 财政年份:2016
- 资助金额:
$ 18.8万 - 项目类别:
Operating Grants














{{item.name}}会员




